Blood Test for Keppra (Levetiracetam) Level
A serum levetiracetam concentration is measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS) or immunoassay methods, with blood samples typically drawn as trough levels (immediately before the next dose). 1, 2
Testing Methodology
The most common laboratory methods for measuring levetiracetam levels include:
LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry): This is a highly specific and sensitive method that can accurately quantify levetiracetam in human plasma, serum, or saliva 1. The method shows excellent precision with within-day coefficients of variation <6.1% and between-day CVs <8.2% 1.
Immunoassay: The ARK immunoassay method on automated platforms provides comparable accuracy to HPLC methods, with within-laboratory imprecision of 3.1-7.4% across therapeutic ranges 2. This method is more readily available in routine clinical laboratories and shows excellent agreement with chromatographic methods 2.
HPLC with Photodiode Array Detection: An alternative chromatographic method that can measure levetiracetam concentrations in plasma 3.
Sample Collection
Draw trough levels - blood samples should be obtained immediately before the next scheduled dose to assess steady-state concentrations. Standard venipuncture with collection into serum or plasma tubes (typically 100 microliters minimum) is sufficient 1.
Therapeutic Range Considerations
While the FDA label does not mandate routine therapeutic drug monitoring 4, research suggests:
- Therapeutic concentrations typically range from 6-20 mg/L in neonates 5 and 12-46 mcg/mL in adults
- A threshold concentration of 11 mcg/mL showed 73% sensitivity and 71% specificity for therapeutic response in refractory epilepsy patients 3
- However, there is wide variability in concentration-response relationships, and levetiracetam serum concentrations of responders versus non-responders did not significantly differ in clinical trials 6
Clinical Utility
Routine monitoring is NOT required according to FDA labeling, as levetiracetam has minimal drug interactions and predictable pharmacokinetics 4. However, monitoring may be indicated for:
- Verifying patient compliance
- Detecting severe intoxication
- Pregnancy (where clearance increases significantly, requiring dose adjustments up to 75% higher than preconception) 7
- Renal impairment (as levetiracetam is primarily renally excreted)
- Neonates and pediatric patients where weight-based dosing and creatinine clearance significantly affect drug disposition 5
Important caveat: Unlike older antiepileptic drugs, levetiracetam levels correlate poorly with clinical efficacy in many patients, so dosing should be guided primarily by clinical response rather than achieving specific target levels 6, 3.